TareBio was founded by Eta Atolia in 2026.

Who are TareBio's investors?

TareBio's investors include Eight Capital, Y Combinator, CCL Investments SaRL, Doomers Media LLC, DTA Capital Advisors, LLC, Grey Street Partners.

Where is TareBio headquartered?

TareBio is headquartered in San Francisco, US.

TareBio

YC S26

San Francisco, US · Founded 2026 · 1 employees · 6 known investors

Find your way into TareBio

Paths you didn't know you had: your email and LinkedIn already hold routes to the TareBio team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

TareBio operates a platform for developing personalized and population-level vaccines against cancer and infectious diseases by analyzing immune cells already responding to a disease and reverse-engineering the antigens that activate them. The company works in the biotechnology and vaccine development space.

Biotech Healthtech Vaccines Synthetic Biology BiotechnologyUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (S26)

TareBio was founded in 2026 by Eta Atolia.

Eta Atolia Founder, CEOEta Atolia is Founder and CEO of TareBio, a biotechnology company developing personalized and population-level vaccines for cancer and infectious diseases. She holds an MD-PhD from UCLA-Caltech, where she developed a vaccine-development platform with Gates Foundation funding, and a BS in Biology from MIT, and has conducted research at the Koch Institute, Harvard Medical School, and the Weizmann Institute.

Investors · 6

Eight Capitallisted by Eight CapitalNorwalk

How we know: Y Combinator's founder network · eightcapital.com · Not right? Tell us

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

CCL Investments SaRLreported

How we know: Y Combinator's founder network · Not right? Tell us

Doomers Media LLCreported

How we know: Y Combinator's founder network · Not right? Tell us

DTA Capital Advisors, LLCreported

How we know: Y Combinator's founder network · Not right? Tell us

Grey Street PartnersreportedMelbourne · $50K

How we know: Y Combinator's founder network · Not right? Tell us

Images

Related companies · 5

Eugit TherapeuticsTissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

Sensible BiotechnologiesSensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.

SolugenSolugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.

MytosMytos develops automated manufacturing technology for regenerative medicines, specifically targeting the production of stem cell-derived therapies to make treatments for conditions like Parkinson's, blindness, and spinal cord injury accessible and affordable to patients.

Volta Labs, Inc.Volta develops a hardware and software platform for genomics sample preparation that automates the extraction of biological information. The company serves researchers, laboratories, and healthcare organizations working in genomics, disease control, forensic science, and medicine.

Companies working in the same space as TareBio.

Legal entities · 1

corporate structure

TareBio, Inc.

In the news

TareBio: Vaccines for any cancer or infection in weeksycombinator.com · Aug 2026

Frequently asked questions

What does TareBio do?: TareBio operates a platform for developing personalized and population-level vaccines against cancer and infectious diseases by analyzing immune cells already responding to a disease and reverse-engineering the antigens that activate them. The company works in the biotechnology and vaccine development space.
Who founded TareBio?: TareBio was founded by Eta Atolia in 2026.
Who are TareBio's investors?: TareBio's investors include Eight Capital, Y Combinator, CCL Investments SaRL, Doomers Media LLC, DTA Capital Advisors, LLC, Grey Street Partners.
Where is TareBio headquartered?: TareBio is headquartered in San Francisco, US.